Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | Director · President and CEO | February 05, 2026 | February 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date February 05, 2026 · Filed February 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.62 · Expires 2035-12-15 | Direct | 145,252 |
Reported balance
After 2026-02-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-05 · Gift · Disposed 145,252 · Balance 145,252 F1: Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5. F2: This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.62 · Expires 2035-12-15 | IndirectBy a trust | 145,252 |
Reported balance
After 2026-02-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-05 · Gift · Acquired 145,252 · Balance 145,252 F1: Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5. F2: This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. F3: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Filing footnotes · ownership attribution and instrument terms
F1: Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5.
F2: This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.
F3: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2025 Filed Jun 12, 2025 20:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 33,504 | $76.22 | $2,553,775.39 |
DisclosureSEC source: 0000950170-25-085748 · ownership.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 114,904 F2 · price: The shares were sold in multiple transactions at prices ranging from $75.555 to $76.50, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 8,683 | $64.60 | $560,921.80 |
DisclosureSEC source: 0000950170-25-085748 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 148,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 25,000 | $45.50 | $1,137,500.00 |
DisclosureSEC source: 0000950170-25-085748 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 139,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 16:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftEmployee Stock Option (Right to Buy) · Derivative | 95,671 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0000950170-25-029982 · ownership.xml · derivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By a trust Disclosed balance after: 95,671 Underlying: Class A Common Stock · 95,671 shares Expires 2034-12-16 F1 · kind: Effective February 27, 2025, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. F2 · derivative.exercise_date: This option was granted for a total of 95,671 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. F3 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 16:04 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftEmployee Stock Option (Right to Buy) · Derivative | 95,671 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0000950170-25-029982 · ownership.xml · derivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,671 Underlying: Class A Common Stock · 95,671 shares Expires 2034-12-16 F1 · kind: Effective February 27, 2025, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. F2 · derivative.exercise_date: This option was granted for a total of 95,671 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 15,477 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138156 · ownership.xml · derivative · entry 8 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 15,477 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F10 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 21,993 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 15,477 PSUs. The remaining 6,516 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. F10 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 21,993 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 15,477 PSUs. The remaining 6,516 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 95,671 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0000950170-24-138156 · ownership.xml · derivative · entry 7 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,671 Underlying: Class A Common Stock · 95,671 shares Expires 2034-12-16 F9 · derivative.exercise_date: This option was granted for a total of 95,671 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 27,212 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138156 · ownership.xml · derivative · entry 6 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,212 Underlying: Class A Common Stock · 27,212 shares Expires not disclosed F8 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F8 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F8 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 31,483 | $79.18 | $2,492,823.94 |
DisclosureSEC source: 0000950170-24-138156 · ownership.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,735 F5 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F6 · balance_after: Shares held following the reported transaction (i) include 127,735 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 23,325 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of restricted stock units. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 15,477 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138156 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F4 · balance_after: Shares held following the reported transactions (i) include 174,745 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 7,679 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of performance-based restricted stock units. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 54,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138156 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,745 F1 · acquired: Award represents a total of 54,425 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 16, 2024. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 174,745 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 17:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,888 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0000950170-24-131633 · ownership.xml · derivative · entry 9 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 0 Underlying: Class A Common Stock · 7,888 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This performance-based stock option award was granted for a total of 90,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 86,400 shares. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 17:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,888 | $80.19 | $632,538.72 |
DisclosureSEC source: 0000950170-24-131633 · ownership.xml · nonDerivative · entry 5 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 83,721 F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 17:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,888 | $62.32 | $491,580.16 |
DisclosureSEC source: 0000950170-24-131633 · ownership.xml · nonDerivative · entry 4 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 91,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 17:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0000950170-24-131633 · ownership.xml · derivative · entry 8 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 7,888 Underlying: Class A Common Stock · 50,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This performance-based stock option award was granted for a total of 90,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 86,400 shares. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 17:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 896 | $81.18 | $72,734.05 |
DisclosureSEC source: 0000950170-24-131633 · ownership.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 83,721 F3 · price: The shares were sold in multiple transactions at prices ranging from $81.135 to $81.215, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 17:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 49,104 | $80.53 | $3,954,232.18 |
DisclosureSEC source: 0000950170-24-131633 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 84,617 F2 · price: The shares were sold in multiple transactions at prices ranging from $80.125 to $81.11, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 17:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 50,000 | $62.32 | $3,116,000.00 |
DisclosureSEC source: 0000950170-24-131633 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 133,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 17:14 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 28,512 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0000950170-24-115380 · ownership.xml · derivative · entry 5 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 57,888 Underlying: Class A Common Stock · 28,512 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This performance-based stock option award was granted for a total of 90,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 86,400 shares. F2 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 17:14 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 9,816 | $74.55 | $731,750.41 |
DisclosureSEC source: 0000950170-24-115380 · ownership.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 83,721 F4 · price: The shares were sold in multiple transactions at prices ranging from $74.38 to $74.74, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 17:14 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 18,696 | $73.90 | $1,381,632.53 |
DisclosureSEC source: 0000950170-24-115380 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 93,537 F3 · price: The shares were sold in multiple transactions at prices ranging from $73.38 to $74.375, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 17:14 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 28,512 | $62.32 | $1,776,867.84 |
DisclosureSEC source: 0000950170-24-115380 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By a trust Disclosed balance after: 112,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The shares held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 reported in the Form 4 filed for the Reporting Person on June 25, 2024 were incorrectly reported as 83,271. The correct amount was 83,721 at that time, and the shares held reported herein reflect the corrected amount. F2 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| June 17, 2024 Filed Jun 25, 2024 21:28 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | PurchaseClass A Common Stock | 2.5592 | $78.15 | $200.00 |
DisclosureSEC source: 0000950170-24-077565 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By a son Disclosed balance after: 2.5592 F1 · kind: This indirect purchase by a family member of the reporting person occurred without the reporting person's knowledge and is being reported within two business days of the reporting person being made aware of the transaction. The indirect purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 2.5592 shares, with a sale by the reporting person of DLB Class A common stock at a maximum price of $83.92 per share on January 17, 2024. The reporting person has paid to the Issuer $14.77, representing the full amount of the profit imputed to the reporting person in connection with the matching transactions. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 16:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftEmployee Stock Option (Right to Buy) · Derivative | 81,884 | $0.00 Strike: $87.49 | $0.00 |
DisclosureSEC source: 0000950170-24-015250 · ownership.xml · derivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By a trust Disclosed balance after: 81,884 Underlying: Class A Common Stock · 81,884 shares Expires 2033-12-15 F1 · kind: Effective February 12, 2024, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. F2 · derivative.exercise_date: This option was granted for a total of 81,884 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. F3 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 16:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GiftEmployee Stock Option (Right to Buy) · Derivative | 81,884 | $0.00 Strike: $87.49 | $0.00 |
DisclosureSEC source: 0000950170-24-015250 · ownership.xml · derivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,884 Underlying: Class A Common Stock · 81,884 shares Expires 2033-12-15 F1 · kind: Effective February 12, 2024, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. F2 · derivative.exercise_date: This option was granted for a total of 81,884 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 16:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,784 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0000950170-24-005798 · ownership.xml · derivative · entry 6 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By a trust Disclosed balance after: 185,615 Underlying: Class A Common Stock · 8,784 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 16:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 246 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0000950170-24-005798 · ownership.xml · derivative · entry 5 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By a trust Disclosed balance after: 0 Underlying: Class A Common Stock · 246 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 16:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 9,030 | $83.51 | $754,082.66 |
DisclosureSEC source: 0000950170-24-005798 · ownership.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By a trust Disclosed balance after: 83,721 F2 · price: The shares were sold in multiple transactions at prices ranging from $83.34 to $83.92, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 16:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 8,784 | $45.50 | $399,672.00 |
DisclosureSEC source: 0000950170-24-005798 · ownership.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By a trust Disclosed balance after: 92,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 16:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 246 | $42.98 | $10,573.08 |
DisclosureSEC source: 0000950170-24-005798 · ownership.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By a trust Disclosed balance after: 83,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 19:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 5,268 | $87.49 | $460,897.32 |
DisclosureSEC source: 0001209191-23-059262 · doc4.xml · nonDerivative · entry 4 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,320 F5 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F7 · balance_after: Shares held following reported transactions (i) include 120,320 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 5,357 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of restricted stock units. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 17,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059262 · doc4.xml · derivative · entry 8 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 17,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F11 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 21,394 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 17,202 PSUs. The remaining 4,192 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. F11 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 21,394 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 17,202 PSUs. The remaining 4,192 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 81,884 | $0.00 Strike: $87.49 | $0.00 |
DisclosureSEC source: 0001209191-23-059262 · doc4.xml · derivative · entry 7 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,884 Underlying: Class A Common Stock · 81,884 shares Expires 2033-12-15 F10 · derivative.exercise_date: This option was granted for a total of 81,884 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 23,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059262 · doc4.xml · derivative · entry 6 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,359 Underlying: Class A Common Stock · 23,359 shares Expires not disclosed F9 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F9 · kind: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F9 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F9 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 26,047 | $88.60 | $2,307,764.20 |
DisclosureSEC source: 0001209191-23-059262 · doc4.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,945 F5 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F6 · balance_after: Shares held following the reported transaction (i) include 130,945 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 17,812 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of restricted stock units. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 17,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-059262 · doc4.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F4 · balance_after: Shares held following the reported transactions (i) include 166,275 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest and (ii) exclude 8,673 shares which were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 in connection with the vesting of performance-based restricted stock units. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 46,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059262 · doc4.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,275 F1 · acquired: Award represents a total of 46,718 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2023. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 166,275 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 17:58 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 18,060 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-23-058686 · doc4.xml · derivative · entry 4 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 246 Underlying: Class A Common Stock · 18,060 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 17:58 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 18,060 | $89.17 | $1,610,435.48 |
DisclosureSEC source: 0001209191-23-058686 · doc4.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 51,879 F1 · price: The shares were sold in multiple transactions at prices ranging from $88.96 to $89.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 17:58 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 18,060 | $42.98 | $776,218.80 |
DisclosureSEC source: 0001209191-23-058686 · doc4.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 69,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 16:58 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 45,150 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-23-056594 · doc4.xml · derivative · entry 5 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 18,306 Underlying: Class A Common Stock · 45,150 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 16:58 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 36,120 | $85.00 | $3,070,200.00 |
DisclosureSEC source: 0001209191-23-056594 · doc4.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 51,879 Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 16:58 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 9,030 | $83.98 | $758,378.23 |
DisclosureSEC source: 0001209191-23-056594 · doc4.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 87,999 F1 · price: The shares were sold in multiple transactions at prices ranging from $83.45 to $84.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 16:58 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 45,150 | $42.98 | $1,940,547.00 |
DisclosureSEC source: 0001209191-23-056594 · doc4.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 97,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2023 Filed Oct 19, 2023 17:17 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 9,030 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-23-053191 · doc4.xml · derivative · entry 6 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 63,456 Underlying: Class A Common Stock · 9,030 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| October 17, 2023 Filed Oct 19, 2023 17:17 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 300 | $82.89 | $24,866.01 |
DisclosureSEC source: 0001209191-23-053191 · doc4.xml · nonDerivative · entry 4 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 51,879 F3 · price: The shares were sold in multiple transactions at prices ranging from $82.88 to $82.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| October 17, 2023 Filed Oct 19, 2023 17:17 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,054 | $82.49 | $581,850.60 |
DisclosureSEC source: 0001209191-23-053191 · doc4.xml · nonDerivative · entry 3 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 52,179 F2 · price: The shares were sold in multiple transactions at prices ranging from $81.88 to $82.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| October 17, 2023 Filed Oct 19, 2023 17:17 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,676 | $81.53 | $136,642.10 |
DisclosureSEC source: 0001209191-23-053191 · doc4.xml · nonDerivative · entry 2 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 59,233 F1 · price: The shares were sold in multiple transactions at prices ranging from $80.805 to $81.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| October 17, 2023 Filed Oct 19, 2023 17:17 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 9,030 | $42.98 | $388,109.40 |
DisclosureSEC source: 0001209191-23-053191 · doc4.xml · nonDerivative · entry 1 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 60,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2023 Filed Sep 14, 2023 19:41 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 18,060 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0001209191-23-049516 · doc4.xml · derivative · entry 5 YEAMAN KEVIN J · CIK 0001200469 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Disclosed balance after: 72,486 Underlying: Class A Common Stock · 18,060 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.